Title

Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2)

UMMS Affiliation

Department of Medicine

Publication Date

2021-02-09

Document Type

Article

Disciplines

Health Services Administration | Health Services Research | Infectious Disease | Internal Medicine | Patient Safety | Therapeutics | Virus Diseases

Abstract

Practice points for clinicians developed by the American College of Physicians addressing these questions: What are the effectiveness and harms of remdesivir in hospitalized patients with coronavirus disease 2019 (COVID-19)? Do effectiveness and harms in hospitalized patients with COVID-19 vary by symptom duration, disease severity, and treatment duration?

Keywords

remdesivir, hospitalized patients, coronavirus disease 2019, COVID-19, effectiveness, harms

DOI of Published Version

10.7326/M20-8101

Source

Qaseem A, Yost J, Etxeandia-Ikobaltzeta I, Abraham GM, Jokela JA, Forciea MA, Miller MC, Humphrey LL. Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2). Ann Intern Med. 2021 Feb 9. doi: 10.7326/M20-8101. Epub ahead of print. PMID: 33560862. Link to article on publisher's site

Journal/Book/Conference Title

Annals of internal medicine

Related Resources

Link to Article in PubMed

PubMed ID

33560862

Share

COinS